These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6217786)

  • 1. Comparative penetration of azlocillin and mezlocillin into cerebrospinal fluid of normal rabbits and rabbits with experimentally induced Pseudomonas aeruginosa meningitis.
    Hodges GR; Worley SE
    Antimicrob Agents Chemother; 1982 Nov; 22(5):909-11. PubMed ID: 6217786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo action of mezlocillin and azlocillin combined with sisomicin.
    Dzierzanowska D; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Sep; 255(2-3):346-55. PubMed ID: 6417945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin.
    Coppens L; Klastersky J
    Antimicrob Agents Chemother; 1979 Mar; 15(3):396-9. PubMed ID: 111610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of therapeutic efficacy of ureidopenicillins in comparison to sisomicin and cephalotin in experimental infections of rabbits.
    Dzierzanowska D; Klosinska E; Roszkowski W; Patzer J; Jeljaszewicz J
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Sep; 250(3):312-21. PubMed ID: 6458186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The passage of mezlocillin into the cerebrospinal fluid. An experimental study in dogs with normal meninges and with Staphylococcus aureus meningitis (author's transl)].
    Armengaud M; Massip P; Tran Van Tho A; Chan Lai Wane L
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):368-72. PubMed ID: 6460978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
    Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
    Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudomonas aeruginosa meningitis treated with an azlocillin combination.
    Davidson S; Yellin EO; Shaked I; Rubinstein E
    Infection; 1982; 10 Suppl 3():S168-9. PubMed ID: 6818154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of azlocillin and mezlocillin combined with aminoglycoside antibiotics and cephalosporins.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1978 May; 13(5):813-9. PubMed ID: 666302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with azlocillin.
    Sanders WE
    J Antimicrob Chemother; 1983 May; 11 Suppl B():69-75. PubMed ID: 6619034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Killing of azlocillin- and mezlocillin-induced filamentous forms of Pseudomonas aeruginosa by decreasing concentrations of penicillin.
    Metzger K
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():11-4. PubMed ID: 6210657
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of mezlocillin in discriminative animal models of infection.
    Scheld WM; Brodeur JP; Keeley JM
    J Antimicrob Chemother; 1982 Jan; 9 Suppl A():51-64. PubMed ID: 6210683
    [No Abstract]   [Full Text] [Related]  

  • 13. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM; Moellering RC
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences using acylureido-penicillins (azlocillin, mezlocillin) in pediatrics].
    Weingärtner L; Sitka U; Patsch R; Thiemann HH
    Klin Padiatr; 1984; 196(1):28-35. PubMed ID: 6694339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
    Monteil H; Peladan F; Zinsius M
    Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The acylampicillins: mezlocillin, piperacillin, and azlocillin.
    Drusano GL; Schimpff SC; Hewitt WL
    Rev Infect Dis; 1984; 6(1):13-32. PubMed ID: 6369480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic studies of azlocillin, mezlocillin, cephalothin and sisomicin in rabbits.
    Dzierzanowska D; Patzer J; Jeljaszewicz J
    Infection; 1982; 10 Suppl 3():S217-20. PubMed ID: 6218118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activities of tobramycin and azlocillin alone and in combination against experimental osteomyelitis caused by Pseudomonas aeruginosa.
    Norden CW; Shaffer MA
    Antimicrob Agents Chemother; 1982 Jan; 21(1):62-5. PubMed ID: 6805423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH
    Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of piperacillin compared with that of ampicillin, ticarcillin, azlocillin, and mezlocillin.
    Machka K; Dickert H; Braveny I
    Arzneimittelforschung; 1980; 30(2):304-7. PubMed ID: 6445735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.